The company is a manufacturer of plasmid DNA medicines that adhere to the highest quality and compliance standards. Genopis serves as a cGMP manufacturing site with current capabilities for microbial-based products, and has plans for future expansion into mammalian-based products. Their focus on plasmid DNA technology and CDMO opportunities allows other businesses to achieve their goals in a cost-effective and efficient manner.